Aurora Cannabis launches Daily Special in Germany

Executive Summary

• Aurora Cannabis Inc. has launched "Daily Special," a new medical cannabis brand specifically for the German market, aiming to provide high-quality, affordable flower to patients.
• The launch is positioned as a strategic move to strengthen Aurora's presence in Germany, one of the world's most important medical cannabis markets, following the company's record performance.
• The product is available at German pharmacies and via telemedicine platforms starting December 19, 2025.

Key Details

• Product Name: Daily Special (Sativa-dominant cultivar).
• Genetics: Born from Gelonade Biscotti.
• Cannabinoid Profile: 21% to 23% THC; less than 1% CBD.
• Flavor/Aroma Profile: Intense citrus, sweet-earthy, and diesel-forward aromas with a rich terpene profile.
• Quality Standards: Produced under global Good Manufacturing Practice (GMP) standards.
• Availability: German pharmacies and Telemedicine platforms.
• Launch Date: December 19, 2025.
• Strategic Context: Part of Aurora's effort to expand patient choice and affordability in the rapidly growing German medical cannabis sector.

Notable Quotes

• "The launch of Daily Special in Germany is a clear demonstration of Aurora's long-term investment and leadership in one of the world's most important medical cannabis markets and key region for the company," said Andreas Dotterweich, senior vice-president, Aurora Europe.